Shanghai Electric Concludes Eight-Day Upskilling Program for Pakistan’s Thar Project Employees
Committed to fostering skilled professionals in modern energy and industry, the Company…
Basilea announces agreement with Innoviva Specialty Therapeutics for the commercialization of antibiotic Zevtera (ceftobiprole) in the United States
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, December 16,…
Akoustis to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process
Committed to Full Continuity in Delivering Next-Generation BAW High-Band RF Filters to…
Rakovina Therapeutics Announces Closing of Oversubscribed $3M Private Placement
December 13, 2024 18:50 ET | Source: Rakovina Therapeutics Inc VANCOUVER, British…
NextCure Announces Acceptance of IND Application for LNCB74
LNCB74 is a B7-H4-targeting antibody-drug conjugate being developed for multiple cancers in…
Affimed Announces Positive Results Demonstrating Safety and Efficacy of Acimtamig and AlloNK Combination in Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL) Patients
December 08, 2024 12:00 ET | Source: Affimed N.V. The combination of…
Orca Bio Presents Clinical Results on Use of Orca-Q without GvHD Prophylaxis in Patients with Hematological Malignancies at the 66th ASH Annual Meeting
Orca-Q allogeneic T-cell immunotherapy with no GvHD prophylaxis in patients with matched…
Fobi AI Provides Update on Current Cease Trade Order
December 06, 2024 20:34 ET | Source: Fobi AI Inc. VANCOUVER, British…
Rakovina Therapeutics Increases Private Placement Offering to $3.0 Million
December 02, 2024 18:22 ET | Source: Rakovina Therapeutics Inc VANCOUVER, British…
Rakovina Therapeutics Announces 2024 Q3 Financial Results and Provides Corporate Update
All dollar amounts reflected in Canadian dollars unless otherwise stated November 29,…